The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.

Login
EN
+7 (495) 482-4118
+7 (495) 482-4329
+8 800 250-18-12
  • (toll-free number for subscriptions)
    Mon-Fri from 10 a.m. to 6 p.m.

  • © 1998-2025
+7 (495) 482-43-29
EN
All journals
Journal
Year
Year
Search result: 0

Yakovleva A.A.

Zakusov Institute of Pharmacology

Litvinova S.A.

Zakusov Institute of Pharmacology

Gladysheva N.A.

Zakusov Institute of Pharmacology

Radontseva V.V.

Zakusov Institute of Pharmacology

Voronina T.A.

Zakusov Research Pharmacology Institute

Experimental study of the influence of phenozanic acid and its combination with valproic acid on the development of the epileptic system

Authors:

Yakovleva A.A., Litvinova S.A., Gladysheva N.A., Radontseva V.V., Voronina T.A.

More about the authors

Journal: S.S. Korsakov Journal of Neurology and Psychiatry. 2024;124(3): 104‑113

DOI: 10.17116/jnevro2024124031104

Read: 1299 times

Download PDF (RU)
Contact the author
Table of contents

EXPERIMENTAL STUDY OF THE INFLUENCE OF PHENOZANIC ACID AND ITS COMBINATION WITH VALPROIC ACID ON THE DEVELOPMENT OF THE EPILEPTIC SYSTEM
EXPERIMENTAL STUDY OF THE INFLUENCE OF PHENOZANIC ACID AND ITS COMBINATION WITH VALPROIC ACID ON THE DEVELOPMENT OF THE EPILEPTIC SYSTEM

To cite this article:

Yakovleva AA, Litvinova SA, Gladysheva NA, Radontseva VV, Voronina TA. Experimental study of the influence of phenozanic acid and its combination with valproic acid on the development of the epileptic system. S.S. Korsakov Journal of Neurology and Psychiatry. 2024;124(3):104‑113. (In Russ.)
https://doi.org/10.17116/jnevro2024124031104

Подписка 2026 Журнал неврологии и психиатрии им. С.С. Корсакова (S.S. Korsakov Journal of Neurology and Psychiatry)
МСФ на ЯМ
Использование инфографики авторами научных работ
Close metadata
Recommended articles:
Personality profile caused by epilepsy acco­rding to the «Big Five» model. S.S. Korsakov Journal of Neurology and Psychiatry. 2024;(10):16-21
Brain microstructural abno­rmalities asse­ssed by diffusion kurtosis MRI in patients with focal temporal lobe epilepsy. S.S. Korsakov Journal of Neurology and Psychiatry. 2024;(11):171-177
Ototoxicity caused by anti-epileptic drugs. S.S. Korsakov Journal of Neurology and Psychiatry. 2024;(12):14-19
Abse­nce status epilepticus in adults. S.S. Korsakov Journal of Neurology and Psychiatry. 2024;(12):47-56
Como­rbid anxiety diso­rders in patients with neurological pathology: current state of the problem and the role of etifoxine in treatment stra­tegy. S.S. Korsakov Journal of Neurology and Psychiatry. 2024;(12):126-136
Auto­nomic cardiovascular diso­rders in patients with epileptic and psychogenic non-epileptic seizures: a pilot study. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(2):13-20
The pote­ntial of cortical electrical stimulation for the study of auto­nomic dysfunction in patients with epilepsy. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(8):25-34
The role of neuroinflammation in the deve­lopment of seizure acti­vity and auto­nomic diso­rders in patients with epilepsy. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(8):50-58
Epileptogenesis and risk factors of symptomatic epileptic seizures in patients with acute cere­brovascular acci­dents. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(8-2):26-31
A personalized approach to the diagnosis of epilepsy in obese children. Labo­ratory Service. 2025;(1):5-12
Abstract:

OBJECTIVE

To study the effect of phenosanic acid (PA) and its combination with valproic acid (VA) on the development of the Epi system.

MATERIAL AND METHODS

A model of focal chronic epilepsy in rats was created by applying metallic cobalt to the surface of the sensorimotor area of the cortex. Long-term electrodes were implanted in the sensorimotor cortex of the left and right hemispheres, the hippocampus, and the hypothalamus. The effect of PA (80 mg/kg) and its combination with VA (200 mg/kg) on discharge activity was carried out on the 2nd day and at the stage of generalization of the Epi system — on the 6th day. The stability of the Epi system on day 10 was assessed by provoking the development of epileptic status (Epi status) in response to the administration of thiolactone homocysteine (HMC) at a dose of 5.5 mmol/kg.

RESULTS

In rats treated with PA, low discharge activity is observed, which is confirmed by the absence of EEG and motor manifestations of status epilepticus caused by HMC. PA does not suppress paroxysmal activity at the stages of development of the Epi system. VA significantly suppresses paroxysmal activity, but does not affect the formation of new foci of Epi activity in subcortical structures and the contralateral cortex. The epi system of rats treated with VA is characterized by high discharge activity by the 10th day of the experiment and lability to provocation of epi status. The combination of drugs is more pronounced than PA, but less than VA, reduces the numerical characteristics of paroxysmal activity in the brain structures of rats.

CONCLUSION

PA when administered alone, in combination with VA, causes a slowdown in the generalization of convulsive foci of Epi activity and prevents the formation of a stable Epi system. VA, having a pronounced anticonvulsant effect, does not weaken the development of the Epi system in the model of focal cobalt-induced epilepsy.

Keywords:

phenosanic acid
Dibufelon
convulsions
valproic acid
epilepsy
epileptic system

Authors:

Yakovleva A.A.

Zakusov Institute of Pharmacology

Litvinova S.A.

Zakusov Institute of Pharmacology

Gladysheva N.A.

Zakusov Institute of Pharmacology

Radontseva V.V.

Zakusov Institute of Pharmacology

Voronina T.A.

Zakusov Research Pharmacology Institute

Received:

06.02.2024

Accepted:

07.02.2024

Close metadata

References:

  1. Karlov VA. Epilepsy in children and adult women and men: a guide for doctors. M.: Medicine; 2019. (In Russ.).
  2. Avakyan GN, Voronina TA, Khromykh EA. Epilepsy. Pathogenesis. pathogenic therapy. A guide for doctors. M. 2007. (In Russ.).
  3. Avakyan GN, Avakyan GG. Transformations of the epileptic system. The state of the issue and the possibility of solving the problem. Epilepsy and Paroxysmal Conditions. 2017;2:34-39. (In Russ.). https://doi.org/10.17749/2077-8333.2017.9.2.006-019
  4. Kryzhanovsky GN. Fundamental mechanisms and general patterns of dysregulatory pathology of the nervous system. M.: Medicine; 2009. (In Russ.).
  5. Karlov VA. Epilepsy. M.: Medicine; 1990. (In Russ.).
  6. Burd SG, Lebedeva AV, Pantina NV, et al. Clinical results and prospects for the use of phenosanic acid in patients with focal epilepsy. Zhurnal Nevrologii i Psikhiatrii im. S.S. Korsakova. 2021;121(10):52-59. (In Russ.). https://doi.org/10.17116/jnevro202112110152
  7. Palmina NP, Maltseva EL, Pynzar EI, et al. Modification of protein kinase activity with ligands in ultra-low concentrations. The role of protein kinase C in peroxide oxidation processes. Ross Chem Zhurn. 1999;43(5):55-62. (In Russ.).
  8. Karlov VA. Epilepsy in children and adult women and men. M.: MEDpress. 2010. (In Russ.).
  9. Rahman M, Awosika AO, Nguyen H. Valproic Acid. 2023 Aug 17. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2024 Jan. 
  10. Owens MJ, Nemeroff CB. Pharmacology of valproate. Psychopharmacol Bull. 2003;37 Suppl 2:17-24. 
  11. Arzamastsev BV, Berezovskaya IV, Verstakova OL, et al. Guidelines for studying the general toxic effects of drugs. Guidelines for conducting preclinical studies of drugs. M. 2012;1(1):21-28. (In Russ.).
  12. Avakyan GN, Nerobkova LN, Voronina TA, et al. The influence of carbamazepine on structural and functional connections in the development of the epileptic system. Eksperimental’naya i Klinicheskaya Farmakologiya. 2002;2:7-10. (In Russ.).
  13. Li D, Luo D, Wang J, et al. Electrical stimulation of the endopiriform nucleus attenuates epilepsy in rats by network modulation. Ann Clin Transl Neurol. 2020;7(12):2356-2369. https://doi.org/10.1002/acn3.51214
  14. Voronina TA, Nerobkova LN. Guidelines for the Study of the anticonvulsant activity of pharmacological substances. Guidelines for conducting pre-clinical trials of medicinal products. 2012;1(14):235-250. (In Russ.).
  15. Dow RS, Fernández-Guardiola A, Manni E. The production of cobalt experimental epilepsy in the rat. Electroencephalogr Clin Neurophysiol. 1962;14(3):399-407.  https://doi.org/10.1016/0013-4694(62)90116-5
  16. Chusid JG, Kopeloff LM. Epileptogenic effects of pure metals implanted in motor cortex of monkeys. J Appl Physiol. 1962;17:697-700.  https://doi.org/10.1152/jappl.1962.17.4.697
  17. Voronina TA, Stoiko MI, Nerobkova LN, et al. Investigation of the effect of fenitoin on the development of homocysteine induced convulsions and epileptic status in rats with cobalt-induced epilepsy. Eksp Klin Farmakol. 2002;65:15-18. (In Russ.).
  18. Litvinova SA, Voronina TA, Nerobkova LN, et al. Peculiarities of the effect of Levetinol on the development of convulsive activity in rats with cobalt-induced chronic epilepsy. Epilepsy and Paroxysmal Conditions. 2018;1:52-61. (In Russ). https://doi.org/10.17749/2077-8333.2018.10.1.052-062
  19. Chang JH, Yang XF, Zempel JM, Rothman SM. The unilateral cobalt wire model of neocortical epilepsy: a method of producing subacute focal seizures in rodents. Epilepsy Res. 2004;61(1-3):153-60.  https://doi.org/10.1016/j.eplepsyres.2004.07.012
  20. Buresh Dz, Petran’ M, Zakhar D. Electrophysiological Methods in Biology. Research. Prague. 1960.
  21. Voronina TA. Pioneer of antioxidant neuroprotection. 20 years in clinical practice. RMZh. 2016;7:434-438. (In Russ.).
  22. Litvinova SA, Avakyan GG, Voronina TA, et al. Comparison of the effects and electrophysiological mechanisms of action of valproic acid and levetiracetam in an experimental model of focal epilepsy. Annals of Clinical and Experimental Neurology. 2018;12(3):45-53. (In Russ.). https://doi.org/10.25692/ACEN.2018.3.6
  23. Yakovleva AA, Ltvinova SA, Voronina TA, et al. Study of the potentiation of the effects of valproic acid and carbamazepine by fenosanic acid with the analysis of neurochemical parameters. Experimental and Clinical Pharmacology. 2022;85:31-37. (In Russ.). https://doi.org/10.30906/0869-2092-2022-85-12-31-37
  24. Bonvallet M, Dell P, Hugelin AJ. Projections olfactives, gustatives, visckrales, vagales, visuelles et auditives au niveau des formations grises du cerveau anterieur du chat. J Physiol. 1952;44:222-224. 
  25. Kaplan DI, Isom LL, Petrou S. Role of Sodium Channels in Epilepsy. Cold Spring Harb Perspect Med. 2016;6(6):a022814. https://doi.org/10.1101/cshperspect.a022814
  26. Abdelsayed M, Sokolov S. Voltage-gated sodium channels: pharmaceutical targets via anticonvulsants to treat epileptic syndromes. Channels (Austin). 2013;7(3):146-152.  https://doi.org/10.4161/chan.24380
  27. Brake N, Mancino AS, Yan Y, et al. Closed-state inactivation of cardiac, skeletal, and neuronal sodium channels is isoform specific. J Gen Physiol. 2022 Jul 4;154(7):e202112921. https://doi.org/10.1085/jgp.202112921
  28. Errington AC, Stöhr T, Heers C, Lees G. The investigational anticonvulsant lacosamide selectively enhances slow inactivation of voltage-gated sodium channels. Mol Pharmacol. 2008;73(1):157-169.  https://doi.org/10.1124/mol.107.039867
  29. Franceschetti S, Taverna S, Sancini G, et al. Protein kinase C-dependent modulation of Na+ currents increases the excitability of rat neocortical pyramidal neurones. J Physiol. 2000;528(Pt 2):291-304.  https://doi.org/10.1111/j.1469-7793.2000.00291.x
  30. Yu FH, Catterall WA. Overview of the voltage-gated sodium channel family. Genome Biol. 2003;4(3):207-213.  https://doi.org/10.1186/gb-2003-4-3-207
  31. Curia G, Aracri P, Colombo E, et al. Phosphorylation of sodium channels mediated by protein kinase-C modulates inhibition by topiramate of tetrodotoxin-sensitive transient sodium current. Br J Pharmacol. 2007;150(6):792-797.  https://doi.org/10.1038/sj.bjp.0707144
  32. Dmitrenko DV, Schneider NA. Teratogenesis of antiepileptic drugs: review of the literature and own observations. Epilepsy and Paroxysmal Conditions. 2014;6(2):61-70. (In Russ.).
  33. Stanojlović O, Rašić-Marković A, Hrnčić D, et al. Two Types of Seizures in Homocysteine Thiolactone-Treated Adult Rats, Behavioral and Electroencephalographic Study. Cell Mol Neurobiol. 2008;29(3):329-339.  https://doi.org/10.1007/s10571-008-9324-8
  34. Reddy DS, Kuruba R. Experimental models of status epilepticus and neuronal injury for evaluation of therapeutic interventions. Int J Mol Sci. 2013;14(9):18284-18318. https://doi.org/10.3390/ijms140918284
Contact the author
Email
Message
The publishing house "Media Sphere" does not provide treatment services, does not give recommendations on contacting medical institutions and specific specialists, on the prescription of medicines and dietary supplements.

Email Confirmation

An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.

Email Confirmation

Contact us
If you have any questions, complaints or suggestions, please use this feedback form.
Email
Message
The publishing house "Media Sphere" does not provide treatment services, does not give recommendations on contacting medical institutions and specific specialists, on the prescription of medicines and dietary supplements.
Submit Application

You can become an author of one of our magazines, send a request and we will consider it in during the day.

Name
Phone
E-mail
Message
Login
Registration
E-mail
Password
Forgot Password?

Log in to the site using your account in one of the services

Password recovery
E-mail
Login
Register

We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.